These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31187118)

  • 1. Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions.
    Levin ED; Wells C; Slade S; Lee M; McKinney AA; Rose JE; Rezvani AH
    Nicotine Tob Res; 2020 Feb; 22(2):232-237. PubMed ID: 31187118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amitifadine, a triple monoamine re-uptake inhibitor, reduces nicotine self-administration in female rats.
    Levin ED; Wells C; Johnson JE; Rezvani AH; Bymaster FP; Rose JE
    Eur J Pharmacol; 2015 Oct; 764():30-37. PubMed ID: 26101069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amitifadine, a triple reuptake inhibitor, reduces self-administration of the opiate remifentanil in rats.
    Levin ED; Wells C; Hawkey A; Holloway Z; Blair G; Vierling A; Ko A; Pace C; Modarres J; McKinney A; Rezvani AH; Rose JE
    Psychopharmacology (Berl); 2020 Jun; 237(6):1681-1689. PubMed ID: 32125484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biopharmaceutical characterization, metabolism, and brain penetration of the triple reuptake inhibitor amitifadine.
    Bymaster FP; Chao P; Schulze H; Tran PV; Marshall RD
    Drug Metab Lett; 2013 Mar; 7(1):23-33. PubMed ID: 23826879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of nicotine self-administration by chronic nicotine infusion with H1 histamine blockade in female rats.
    Levin ED; Hall BJ; Chattopadhyay A; Slade S; Wells C; Rezvani AH; Rose JE
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):3009-15. PubMed ID: 27318988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The putative antidepressant DOV 216,303, a triple reuptake inhibitor, increases monoamine release in the prefrontal cortex of olfactory bulbectomized rats.
    Prins J; Denys DA; Westphal KG; Korte-Bouws GA; Quinton MS; Schreiber R; Groenink L; Olivier B; Korte SM
    Eur J Pharmacol; 2010 May; 633(1-3):55-61. PubMed ID: 20153745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D
    DiPalma D; Rezvani AH; Willette B; Wells C; Slade S; Hall BJ; Levin ED
    Pharmacol Biochem Behav; 2019 Jan; 176():16-22. PubMed ID: 30419272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the triple monoamine uptake inhibitor amitifadine on pain-related depression of behavior and mesolimbic dopamine release in rats.
    Miller LL; Leitl MD; Banks ML; Blough BE; Negus SS
    Pain; 2015 Jan; 156(1):175-184. PubMed ID: 25599313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder.
    Xue W; Wang P; Tu G; Yang F; Zheng G; Li X; Li X; Chen Y; Yao X; Zhu F
    Phys Chem Chem Phys; 2018 Feb; 20(9):6606-6616. PubMed ID: 29451287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial.
    Tran P; Skolnick P; Czobor P; Huang NY; Bradshaw M; McKinney A; Fava M
    J Psychiatr Res; 2012 Jan; 46(1):64-71. PubMed ID: 21925682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased nicotine self-administration following prenatal exposure in female rats.
    Levin ED; Lawrence S; Petro A; Horton K; Seidler FJ; Slotkin TA
    Pharmacol Biochem Behav; 2006 Nov; 85(3):669-74. PubMed ID: 17196243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats.
    Johnson JE; Slade S; Wells C; Petro A; Sexton H; Rezvani AH; Brown ML; Paige MA; McDowell BE; Xiao Y; Kellar KJ; Levin ED
    Psychopharmacology (Berl); 2012 Jul; 222(2):269-76. PubMed ID: 22297831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine replacement therapy for smoking cessation.
    Stead LF; Perera R; Bullen C; Mant D; Hartmann-Boyce J; Cahill K; Lancaster T
    Cochrane Database Syst Rev; 2012 Nov; 11():CD000146. PubMed ID: 23152200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine replacement therapy for smoking cessation.
    Silagy C; Mant D; Fowler G; Lancaster T
    Cochrane Database Syst Rev; 2000; (3):CD000146. PubMed ID: 10908462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mecamylamine (a nicotine antagonist) for smoking cessation.
    Lancaster T; Stead LF
    Cochrane Database Syst Rev; 2000; 1998(2):CD001009. PubMed ID: 10796584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amitifadine, a triple monoamine uptake inhibitor, reduces binge drinking and negative affect in an animal model of co-occurring alcoholism and depression symptomatology.
    Warnock KT; Yang AR; Yi HS; June HL; Kelly T; Basile AS; Skolnick P; June HL
    Pharmacol Biochem Behav; 2012 Nov; 103(1):111-8. PubMed ID: 22884707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reinforcing and neural activating effects of norharmane, a non-nicotine tobacco constituent, alone and in combination with nicotine.
    Arnold MM; Loughlin SE; Belluzzi JD; Leslie FM
    Neuropharmacology; 2014 Oct; 85():293-304. PubMed ID: 24907588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-cycloserine selectively decreases nicotine self-administration in rats with low baseline levels of response.
    Levin ED; Slade S; Wells C; Petro A; Rose JE
    Pharmacol Biochem Behav; 2011 Apr; 98(2):210-4. PubMed ID: 21192967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.
    Becker KM; Rose JE; Albino AP
    Nicotine Tob Res; 2008 Jul; 10(7):1139-48. PubMed ID: 18629723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial.
    Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM
    JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.